TARO-ENALAPRIL
Identification of Taro-Enalapril
| No description |
Google image searchProduct monograph
Active ingredient
enalapril sodium, 4 MG
DIN: 02352249
Dosage form(s): TABLET
Route(s) of administration: ORAL
Schedule: Prescription
Company: SUN PHARMA CANADA INC
Date: 15-FEB-2022
ATC:
- C09 — AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM (ATC, ATC/DDD, )
- C09A — ACE INHIBITORS, PLAIN (ATC, ATC/DDD)
- C09AA — ACE inhibitors, plain (ATC, ATC/DDD)
- C09AA02 — ENALAPRIL (ATC/DDD)
Reference brand drug: Vasotec
